Achillion Pharmaceuticals (ACHN)
Achillion Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 2.489M | 0.062M | 0.064M | 0.056M | 0.065M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 2.489M | 0.062M | 0.064M | 0.056M | 0.065M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 8.942M | 9.937M | 8.615M | 8.896M | 7.993M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 2.739M | 2.572M | 1.922M | 2.436M | 2.223M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 11.68M | 12.51M | 10.54M | 11.33M | 10.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -9.192M | -12.45M | -10.47M | -11.28M | -10.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.051M | 0.062M | 0.035M | 0.026M | 0.018M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -9.141M | -12.38M | -10.44M | -11.25M | -10.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -9.141M | -12.38M | -10.44M | -11.25M | -10.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -9.141M | -12.38M | -10.44M | -11.25M | -10.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -9.141M | -12.38M | -10.44M | -11.25M | -10.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 70.41 | 64.25 | 69.72 | 58.94 | 58.39 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 70.41 | 64.25 | 69.72 | 58.94 | 58.39 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.13 | -0.18 | -0.15 | -0.19 | -0.17 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.13 | -0.18 | -0.15 | -0.19 | -0.17 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
